Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

5.05USD
18 Jan 2019
Change (% chg)

$-0.10 (-1.94%)
Prev Close
$5.15
Open
$5.14
Day's High
$5.14
Day's Low
$5.02
Volume
7,994
Avg. Vol
5,924
52-wk High
$10.02
52-wk Low
$4.11

Chart for

About

Arcturus Therapeutics Ltd, formerly Alcobra Ltd, is an Israel-based preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of ribonucleic acid (RNA) medicines using lipid-mediated nanoparticle delivery system (LUNAR) and Unlocked Nucleomonomer Agent (UNA) Oligomer... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $28.94
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.76 -- --
ROI: -41.68 8.99 14.48
ROE: -41.68 10.13 15.99

Earnings vs. Estimates